Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ropivacaine with Dexmedetomidine or Dexamethasone for Paravertebral Block in VATS
NCT03570645Phase 4Completed
- Sponsor
- China Medical University
- Start
- Jul 2019
- Primary completion
- Nov 2019
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of dexmedetomidine, dexamethasone in lung cancer, sponsored by China Medical University. Started Jul 2019; status: completed.
02
Drugs
dexmedetomidinedexamethasone
03
Conditions
lung cancer
Beyond the preview
Go deeper on NCT03570645.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03570645.